We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current JSPRW market cap is 1.47M. The company's latest EPS is USD -4.7443 and P/E is -1.00.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -17.73M | -15.07M | -15.99M | -19.89M | -25.29M |
| Net Income | -16.58M | -13.73M | -14.58M | -18.64M | -24.32M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -935k | -36.83M | -51.2M | -68.86M | -76.24M |
| Net Income | -591k | -30.64M | -37.69M | -64.47M | -71.27M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 94.89M | 125.96M | 113.93M | 99.41M | 79.9M |
| Total Liabilities | 16.45M | 12.73M | 13.62M | 15.73M | 18.23M |
| Total Equity | 78.44M | 113.23M | 100.31M | 83.68M | 61.67M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 101.26M | 93.65M | 48.36M | 94.89M | 79.9M |
| Total Liabilities | 3.77M | 24.14M | 12.37M | 16.45M | 18.23M |
| Total Equity | 5M | 69.52M | 35.99M | 78.44M | 61.67M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -52.07M | -15.74M | -27.42M | -41.47M | -62.6M |
| Investing | -267k | -25k | -182k | -456k | -532k |
| Financing | 100.97M | 47.35M | 47.53M | 47.54M | 47.88M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -641k | -33.68M | -45.86M | -52.07M | -62.6M |
| Investing | 198k | -2.43M | -576k | -267k | -532k |
| Financing | N/A | 100.97M | 55k | 100.97M | 47.88M |
| Market Cap | 1.47M |
| Price to Earnings Ratio | -1.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.99 |
| Price to Book Ratio | 1.15 |
| Dividend Yield | - |
| Shares Outstanding | 15.02M |
| Average Volume (1 week) | 2.13k |
| Average Volume (1 Month) | 3.88k |
| 52 Week Change | -29.73% |
| 52 Week High | 0.2526 |
| 52 Week Low | 0.0605 |
| Spread (Intraday) | 0.1 (60.38%) |
| Company Name | Jasper Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.jaspertherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
